Stryker EBITDA 2010-2025 | SYK

Stryker annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Stryker EBITDA for the quarter ending March 31, 2025 was $1.109B, a 9.98% decline year-over-year.
  • Stryker EBITDA for the twelve months ending March 31, 2025 was $4.616B, a 10.47% decline year-over-year.
  • Stryker 2024 annual EBITDA was $4.739B, a 3.6% decline from 2023.
  • Stryker 2023 annual EBITDA was $4.916B, a 28.05% increase from 2022.
  • Stryker 2022 annual EBITDA was $3.839B, a 7.41% increase from 2021.
Stryker Annual EBITDA
(Millions of US $)
2024 $4,739
2023 $4,916
2022 $3,839
2021 $3,574
2020 $3,035
2019 $3,491
2018 $3,260
2017 $2,939
2016 $2,721
2015 $2,258
2014 $1,624
2013 $1,563
2012 $2,018
2011 $1,846
2010 $1,916
2009 $1,979
Stryker Quarterly EBITDA
(Millions of US $)
2025-03-31 $1,109
2024-12-31 $845
2024-09-30 $1,353
2024-06-30 $1,309
2024-03-31 $1,232
2023-12-31 $1,507
2023-09-30 $1,193
2023-06-30 $1,224
2023-03-31 $992
2022-12-31 $1,067
2022-09-30 $1,058
2022-06-30 $1,025
2022-03-31 $689
2021-12-31 $1,057
2021-09-30 $809
2021-06-30 $973
2021-03-31 $735
2020-12-31 $972
2020-09-30 $1,057
2020-06-30 $173
2020-03-31 $833
2019-12-31 $1,139
2019-09-30 $822
2019-06-30 $812
2019-03-31 $718
2018-12-31 $874
2018-09-30 $761
2018-06-30 $858
2018-03-31 $767
2017-12-31 $883
2017-09-30 $688
2017-06-30 $662
2017-03-31 $706
2016-12-31 $821
2016-09-30 $634
2016-06-30 $645
2016-03-31 $621
2015-12-31 $756
2015-09-30 $479
2015-06-30 $523
2015-03-31 $500
2014-12-31 $564
2014-09-30 $547
2014-06-30 $291
2014-03-31 $222
2013-12-31 $512
2013-09-30 $226
2013-06-30 $401
2013-03-31 $424
2012-12-31 $532
2012-09-30 $488
2012-06-30 $452
2012-03-31 $546
2011-12-31 $219
2011-09-30 $568
2011-06-30 $521
2011-03-31 $538
2010-12-31 $252
2010-09-30 $572
2010-06-30 $547
2010-03-31 $546
2009-12-31 $618
2009-09-30 $500
2009-06-30 $390
2009-03-31 $471
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $144.721B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.851B 27.88
Boston Scientific (BSX) United States $151.436B 37.91
EssilorLuxottica (ESLOY) France $129.653B 0.00
Medtronic (MDT) Ireland $110.247B 15.63
Lonza Group Ag (LZAGY) Switzerland $50.183B 0.00
Haleon (HLN) United Kingdom $47.171B 26.90
ResMed (RMD) United States $37.320B 28.03
Agilent Technologies (A) United States $32.988B 21.51
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Terumo (TRUMY) Japan $26.976B 35.04
Koninklijke Philips (PHG) Netherlands $21.839B 15.32
Insulet (PODD) United States $21.652B 84.99
Zimmer Biomet Holdings (ZBH) United States $18.103B 11.63
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.776B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.410B 22.31
Lantheus Holdings (LNTH) United States $5.591B 14.10
Prestige Consumer Healthcare (PBH) United States $4.170B 18.63
Perrigo (PRGO) Ireland $3.636B 9.22
Haemonetics (HAE) United States $3.462B 15.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.203B 26.62
ICU Medical (ICUI) United States $3.152B 23.24
GN Store Nord (GNNDY) Denmark $2.272B 18.82
LeMaitre Vascular (LMAT) United States $1.884B 42.11
QuidelOrtho (QDEL) United States $1.870B 12.86
AtriCure (ATRC) United States $1.579B 0.00
Acuren (TIC) United States $1.283B 0.00
AdaptHealth (AHCO) United States $1.120B 11.37
Neogen (NEOG) United States $1.035B 13.25
Green Thumb Industries (GTBIF) United States $1.018B 22.91
BioLife Solutions (BLFS) United States $1.015B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.853B 8.59
Kestra Medical Technologies (KMTS) United States $0.822B 0.00
CeriBell (CBLL) United States $0.668B 0.00
Evolus (EOLS) United States $0.605B 0.00
Owens & Minor (OMI) United States $0.562B 4.67
Maravai LifeSciences Holdings (MRVI) United States $0.537B 0.00
Curaleaf Holdings (CURLF) Canada $0.514B 0.00
Valneva SE (VALN) France $0.476B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Tilray Brands (TLRY) Canada $0.363B 0.00
Capricor Therapeutics (CAPR) United States $0.351B 0.00
SNDL (SNDL) Canada $0.326B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.287B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.247B 0.00
Quanterix (QTRX) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.241B 10.95
OraSure Technologies (OSUR) United States $0.227B 0.00
Cresco Labs (CRLBF) United States $0.222B 0.00
Aurora Cannabis (ACB) Canada $0.220B 65.17
Biote (BTMD) United States $0.219B 6.17
Canopy Growth (CGC) Canada $0.219B 0.00
Brainsway (BWAY) Israel $0.217B 57.45
TriSalus Life Sciences (TLSI) United States $0.200B 0.00
Omeros (OMER) United States $0.187B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.52
Verano Holdings (VRNOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.175B 0.00
Organigram Global (OGI) Canada $0.171B 0.00
Exagen (XGN) United States $0.148B 0.00
Vireo Growth (VREOF) United States $0.131B 0.00
FitLife Brands (FTLF) United States $0.122B 15.02
Jin Medical (ZJYL) China $0.101B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.29
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.084B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Cytosorbents (CTSO) United States $0.079B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
TerrAscend (TSNDF) Canada $0.076B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.045B 61.29
Modular Medical (MODD) United States $0.042B 0.00
United-Guardian (UG) United States $0.038B 13.03
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.025B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00